Bibliografisk träff 2010-11-24 Human cytochrome P450 liability studies of trans-dihydronarciclasine: a readily available, potent, and selective cancer cell growth inhibitor. McNulty J, Thorat A, Vurgun N, Nair JJ, Makaji E, Crankshaw DJ, Holloway AC, Pandey S. J Nat Prod · research support, non-u.s. gov't; journal article · DOI 10.1021/np100657w